Amneal Pharmaceuticals Inc.

AMRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$19.44

-$0.72 (-3.57%)

Sep 22, 2026, 11:19 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	3.02B	2.79B	2.39B	2.21B	2.09B	1.99B
Cost of Revenue	1.88B	1.77B	1.53B	1.42B	1.32B	1.36B
Gross Profit	1.14B	1.02B	863.87M	791.46M	768.97M	628.39M
Operating Income	423.09M	249.33M	204.37M	-94.93M	152.72M	91.16M
Interest Income	n/a	n/a	n/a	158.38M	n/a	n/a
Pretax Income	139.21M	-55.01M	-40.27M	-248.13M	31.37M	-35.78M
Net Income	72.06M	-116.89M	-83.99M	-129.99M	10.62M	91.06M
Selling & General & Admin	526.83M	476.44M	429.68M	399.7M	365.5M	326.73M
Research & Development	186.18M	190.71M	194.75M	208.66M	209.56M	190.59M
Other Expenses	n/a	103.96M	35.07M	278.03M	41.19M	19.93M
Operating Expenses	713M	771.11M	659.5M	886.39M	616.26M	537.24M
Interest Expense	241.09M	258.6M	210.63M	158.38M	136.33M	146M
Selling & Marketing Expenses	n/a	34.4M	12.4M	16.8M	n/a	n/a
Cost & Expenses	2.6B	2.54B	2.19B	2.31B	1.94B	1.9B
Income Tax Expense	11.28M	18.86M	8.45M	6.66M	11.2M	-104.36M
Shares Outstanding (Basic)	313.37M	308.98M	174.99M	150.94M	148.92M	149.28M
Shares Outstanding (Diluted)	324.81M	308.98M	176.14M	150.94M	151.82M	148.91M
EPS (Basic)	0.23	-0.38	-0.48	-0.86	0.07	0.62
EPS (Diluted)	0.22	-0.38	-0.48	-0.86	0.07	0.61
EBITDA	603.87M	439.77M	500.78M	440.21M	401.1M	345.61M
EBIT	380.3M	203.58M	271.38M	200.03M	167.69M	110.22M
Depreciation & Amortization	223.57M	236.19M	229.4M	240.18M	233.41M	235.39M